Marathon Money Analyst Report
Biofrontera Inc. (NASDAQ: BFRI)Date: Monday, September 29, 2025 Biofrontera Inc. is a U.S. dermatology biopharma commercializing Ameluz® photodynamic therapy and pursuing label expansions. Recent company updates include a royalty restructuring…